Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I
- 1 May 2006
- journal article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 189 (2), 279-287
- https://doi.org/10.1677/joe.1.06351
Abstract
Parathyroid hormone (PTH) exerts both catabolic and anabolic actions on bone. Studies on the skeletal effects of PTH have seldom considered the effects of gender. Our study was designed to determine whether the response of mouse bone to PTH differed according to sex. As a first step, we analyzed gender differences with respect to bone mass and structural properties of 4 month old PTH treated (80 μg/kg per day for 2 weeks) male and female CD-1 mice. PTH significantly increased fat free weight/body weight, periosteal bone formation rate, mineral apposition rate, and endosteal single labeling surface, while significantly decreasing medullary area in male mice compared with vehicle treated controls, but induced no significant changes in female mice. We then analyzed the gender differences in bone marrow stromal cells (BMSC) isolated from 4 month old male and female CD-1 mice following treatment with PTH (80 μg/kg per day for 2 weeks). PTH significantly increased the osteogenic colony number and the alkaline phosphatase (ALP) activity (ALP/cell) by day 14 in cultures of BMSCs from male and female mice. PTH also increased the mRNA level of receptor activator of nuclear factor κB ligand in the bone tissue (marrow removed) of both females and males. However, PTH increased the mRNA levels of IGF-I and IGF-IR only in the bones of male mice. Our results indicate that on balance a 2-weeks course of PTH is anabolic on cortical bone in this mouse strain. These effects are more evident in the male mouse. These differences between male and female mice may reflect the greater response to PTH of IGF-I and IGF-IR gene expression in males enhancing the anabolic effect on cortical bone.This publication has 35 references indexed in Scilit:
- Differential transcriptional effects of PTH and estrogen during anabolic bone formationJournal of Cellular Biochemistry, 2004
- Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormoneJournal of Cellular Biochemistry, 2003
- Anabolic Action of Parathyroid Hormone Is Skeletal Site Specific at the Tissue and Cellular Levels in MiceJournal of Bone and Mineral Research, 2002
- Discrimination among osteoblasts? Parathyroid hormone analog may reveal site-specific differences in miceBone, 2000
- Anabolic or Catabolic Responses of MC3T3-E1 Osteoblastic Cells to Parathyroid Hormone Depend on Time and Duration of TreatmentJournal of Bone and Mineral Research, 1999
- The Effects of Gonadectomy on Bone Size, Mass, and Volumetric Density in Growing Rats Are Gender-, Site-, and Growth Hormone–SpecificJournal of Bone and Mineral Research, 1999
- Comparison of Recombinant Human PTH(1–34) (LY333334) with a C-Terminally Substituted Analog of Human PTH-Related Protein(1–34) (RS-66271): In Vitro Activity and In Vivo Pharmacological Effects in RatsJournal of Bone and Mineral Research, 1999
- Skeletal Unloading Causes Resistance of Osteoprogenitor Cells to Parathyroid Hormone and to Insulin-like Growth Factor-IJournal of Bone and Mineral Research, 1999
- Regional Responsiveness of the Tibia to Intermittent Administration of Parathyroid Hormone as Affected by Skeletal UnloadingJournal of Bone and Mineral Research, 1997
- Effects of parathyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell proliferationBone, 1996